Hyperoxaluria
Showing 1 - 25 of 87
Cystinosis, Primary Hyperoxaluria Trial in Hanover (Diagnostic test)
Recruiting
- Cystinosis
- Primary Hyperoxaluria
- Diagnostic test
-
Hanover, Lower Saxony, GermanyScreening Laboratory Hanover
Apr 24, 2023
Enteric Hyperoxaluria Trial in New York (Moderately High Oxalate (MOx) Diet)
Recruiting
- Enteric Hyperoxaluria
- Moderately High Oxalate (MOx) Diet
-
New York, New YorkNYU Langone Health
Nov 10, 2022
Healthy, Enteric Hyperoxaluria Trial in Cincinnati (FB-001, Placebo)
Recruiting
- Healthy
- Enteric Hyperoxaluria
- FB-001
- Placebo
-
Cincinnati, OhioMedpace Clinical Pharmacology Unit
Jan 23, 2023
Hyperoxaluria, Nonalcoholic Fatty Liver Disease, Kidney Stone Trial in United States (BMN 255, Placebo)
Recruiting
- Hyperoxaluria
- +2 more
- BMN 255
- Placebo
-
Birmingham, Alabama
- +6 more
Nov 16, 2023
Rare Kidney Stone Consortium Patient Registry
Recruiting
- Primary Hyperoxaluria
- +3 more
-
Rochester, Minnesota
- +3 more
Aug 19, 2022
Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
Recruiting
- Primary Hyperoxaluria Type 1
-
Phoenix, Arizona
- +10 more
Aug 11, 2022
Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)
Enrolling by invitation
- Primary Hyperoxaluria Type 1 (PH1)
- +5 more
-
San Francisco, California
- +19 more
Jun 22, 2022
Phenotyping of Primary Hyperoxaluria
Recruiting
- Primary Hyperoxaluria
-
Strasbourg, FranceService de Néphrologie et Transplantation - Hôpitaux Universitai
Oct 25, 2021
Primary Hyperoxaluria Trial in Bonn (Oxalobacter formigenes)
Completed
- Primary Hyperoxaluria
- Oxalobacter formigenes
-
Bonn, GermanyUniversitätsklinikum Bonn, Department of Paediatric Nephrology
Dec 9, 2021
Primary Hyperoxaluria, Cystinuria, Adenine Phosphoribosyl Transferase Deficiency Trial in Rochester, New York, Reykjavik
Completed
- Primary Hyperoxaluria
- +3 more
- Health-related Quality of Life in Rare Kidney Stone Questionnaire
-
Rochester, Minnesota
- +2 more
Aug 31, 2022
Prospective Research Rare Kidney Stones (ProRKS)
Recruiting
- Hyperoxaluria
- +4 more
-
Birmingham, Alabama
- +10 more
Nov 10, 2022
Primary Hyperoxaluria Type 1 (PH1) Trial in Worldwide (Placebo, Lumasiran)
Active, not recruiting
- Primary Hyperoxaluria Type 1 (PH1)
- Placebo
- Lumasiran
-
San Diego, California
- +15 more
Mar 4, 2022
Hyperoxaluria, Primary Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes Strain HC-1)
Terminated
- Hyperoxaluria, Primary
- Oxabact OC5 - Oxalobacter formigenes Strain HC-1
-
Nashville, Tennessee
- +7 more
Nov 11, 2021
Primary Hyperoxaluria Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes HC-1, Placebo)
Completed
- Primary Hyperoxaluria
- Oxabact OC5 - Oxalobacter formigenes HC-1
- Placebo
-
Nashville, Tennessee
- +9 more
Dec 9, 2021
Urolithiasis, Hyperoxaluria Trial in Vienna (Dapagliflozin, Hydrochlorothiazide)
Not yet recruiting
- Urolithiasis
- Hyperoxaluria
-
Vienna, AustriaMedical University of Vienna
Jun 29, 2022
Healthy Volunteers, Enteric Hyperoxaluria Trial in Canada, United States (combination product, biological, drug)
Recruiting
- Healthy Volunteers
- Enteric Hyperoxaluria
- NOV-001
- +3 more
-
Birmingham, Alabama
- +14 more
Jun 24, 2022
Rare Kidney Stone Consortium Biobank
Recruiting
- Primary Hyperoxaluria
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jul 8, 2021
Primary Hyperoxaluria Type 3 Trial in Worldwide
Recruiting
- Primary Hyperoxaluria Type 3
-
Boston, Massachusetts
- +12 more
Nov 16, 2021
Primary Hyperoxaluria Type 3 Trial in Worldwide (DCR-PHXC, Sterile Normal Saline (0.9% NaCl))
Completed
- Primary Hyperoxaluria Type 3
- DCR-PHXC
- Sterile Normal Saline (0.9% NaCl)
-
Boston, Massachusetts
- +5 more
Sep 9, 2021
Primary Hyperoxaluria Trial in Paris (stiripentol (Diacomit))
Completed
- Primary Hyperoxaluria
- stiripentol (Diacomit)
-
Paris, France
- +2 more
Mar 25, 2021